Athersys, Inc. (ATHXQ)

OTCMKTS · Delayed Price · Currency is USD

0.0001

0.00 (0.00%)

Sep 8, 2026, 9:30 AM EST

Market Cap	62.00
Revenue (ttm)	80.00K -98.7%
Net Income	-37.51M
EPS	-1.89
Shares Out	61.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	n/a
Beta	50.65
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Athersys

Athersys, Inc., a clinical-stage biotechnology company, develops therapies in the regenerative medicine area. Its stem cell product candidate is the MultiStem cell therapy, an allogeneic stem cell product for the treatment of indications in the neurological, inflammatory and immune, and cardiovascular disease areas, as well as other critical care conditions. The company was founded in 1995 and is headquartered in Cleveland, Ohio. On September 24, 2024, the voluntary petition of Athersys, Inc. for reorganization under Chapter 11 was converted to... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1995

Employees 24

Stock Exchange OTCMKTS

Ticker Symbol ATHXQ

Full Company Profile